Peripheral vascular disease (PVD) is narrowing of arteries outside the brain and heart. Risk factors for the growth of PVD include hypertension, obesity, diabetes and smoking. More than 5% of the population above the age of 50 years suffers from PVD. Insufficient blood flow and narrowing of arteries are the most common peripheral diseases caused due to plaque buildup. The global market for peripheral vascular devices was valued at USD 4,802.6 million in 2011, with an expected CAGR of 7.1% from 2012 to 2018. The North American region accounts for the largest market share. Asia-Pacific is the fastest growing market, on account of favorable demographic and economic conditions.
The major segments in the market include peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices and inferior vena cava filters. Embolic protection devices are the fastest growing segment in the total peripheral vascular devices market.
Growth of the global peripheral vascular devices market is fuelled by the rate of population growth globally and the high incidence of peripheral vascular diseases due to increasing aging population. Rising healthcare awareness and increasing disposable incomes are other important factors driving the growth of the market.
Key players such as Abbott Laboratories, Cordis Corporation and Boston Scientific Corporation dominate the market with their global presence. With the increasing aging population in developed economies such as North America and Europe, the demand for peripheral vascular devices would also increase. Asia-Pacific will record a high CAGR, due to the continuous increase in population as well as disposable incomes. Economic growth and technological advancements are primary factors stimulating the growth of peripheral vascular devices market in Asia-Pacific region. Global Peripheral Vascular Devices Market, by Product Types, 2011 (USD Million)
Peripheral vascular disease (PVD) is narrowing of arteries outside brain and heart. Risk factors for the growth of PVD include hypertension, obesity, diabetes and smoking. More than 5% of the population above age 50 years suffers from PVD. Peripheral vascular devices are used for the treatment of these blocked arteries and remove the buildup plaque. Factors such as rapidly growing geriatric population, increasing incidences of peripheral vascular devices, rising minimally invasive surgeries support the growth of peripheral vascular devices market globally. For instance, it has been estimated that globally around 20% of the total population above the age of 65 years are affected by peripheral vascular diseases. In addition, changing lifestyle and increasing healthcare awareness, surge in high risk factors such as smoking and diabetes contributes towards increase in incidence rate of peripheral vascular diseases which would stimulate the growth of peripheral vascular devices market globally.
The research report on peripheral vascular devices market provides detailed analysis of the global market and helps in understanding the driving forces for the growth of these devices. The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. In addition, this section covers market attractiveness analysis (by geography) for the year 2011 and Porter’s Five Forces analysis for the global peripheral vascular devices market.
The report also provides analysis of major segments such as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA Guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices and inferior vena cava filters. Peripheral vascular stents segment is further classified as fem-pop, iliac, renal and carotid. Atherectomy devices are further segmented as rotational atherectomy devices, orbital atherectomy devices, directional atherectomy devices and laser atherectomy devices. In addition, embolic protection devices market segment is categorized as balloon occlusion devices, catheter occlusion devices and filter devices. The inferior vena cava filters segment is classified as retrievable filters and permanent inferior vena cava filters. The market for these segments and sub-segments has been extensively analyzed based on number of procedures performed, reimbursement scenario and cost of the devices. The market size and forecast in terms of USD million for each segment and sub-segment has been provided for the period from 2010 – 2018, considering 2011 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2012 to 2018 for each segment and sub-segment.
The market has also been segmented geographically into four regions namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). The market for peripheral vascular devices has been extensively analyzed based on the number of minimally invasive procedures performed and incidence rate of peripheral vascular diseases in the regions. The market size and forecast in terms of USD million for each geography has been provided for the period from 2010 – 2018, considering 2011 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2012 to 2018 for each region.
The chapter on competitive landscape comprises market share analysis of the global peripheral vascular devices market by key players for 2011, followed by a list of recommendations for the existing and new players. In addition, the report also profiles key players of the market on various parameters such as business overview, financial overview, business strategies, product portfolio and recent developments. Key market players’ profiled in this report are Abbott Laboratories, Angioscore, Inc., Boston Scientific Corporation, C.R.Bard Inc., Cook Group, Inc., Cordis Covidien plc, Edward Lifesciences Corporation, Medtronic, St. Jude Medical, Volcano Corporation and others.